Clinical Trial Detail

NCT ID NCT03404193
Title Venetoclax in Combination With 10-Day Decitabine in Newly Diagnosed Elderly or Relapsed/Refractory Acute Myeloid Leukemia and Relapsed High-risk Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

acute leukemia

chronic myelomonocytic leukemia

myelodysplastic syndrome

Therapies

Decitabine + Venetoclax

Age Groups: adult senior

No variant requirements are available.